Alnylam director granted RSUs and stock options
ALNYLAM PHARMACEUTICALS, INC. director Amy W. Schulman reported equity compensation awards rather than open-market trades.
Rhea-AI Filing Summary
ALNYLAM PHARMACEUTICALS, INC. director Amy W. Schulman reported equity compensation awards rather than open-market trades. On May 20, 2026, she received 838 restricted stock units (RSUs), each representing one share of common stock, increasing her direct common stock holdings to 24,049 shares after the grant.
She was also granted stock options on 1,802 shares of common stock with a $298.48 exercise price, expiring on May 20, 2036. Both the RSUs and options vest in full on the earlier of the first anniversary of the grant date or a qualifying retirement or resignation that occurs no more than 90 days before that anniversary.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 2,640 shares
Grant/Award
2 txns
Insider
SCHULMAN AMY W
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 1,802 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 838 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 1,802 contracts (Direct);
Common Stock — 24,049 shares (Direct)
Footnotes (2)
- F1. These shares are represented by restricted stock units (RSUs) granted under the Second Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.
- F2. The stock option will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.
Key Figures
RSU grant: 838 RSUs
Options granted: 1,802 options
Option exercise price: $298.48 per share
+2 more
5 metrics
RSU grant
838 RSUs
Restricted stock units granted on May 20, 2026
Options granted
1,802 options
Stock options on common stock granted May 20, 2026
Option exercise price
$298.48 per share
Conversion or exercise price for 1,802 options
Shares held after RSU grant
24,049 shares
Total direct common stock following RSU award
Option expiration
May 20, 2036
Expiration date of stock option grant
Key Terms
restricted stock units (RSUs), Stock Option (Right to Buy), Second Amended and Restated 2018 Stock Incentive Plan, vesting
4 terms
restricted stock units (RSUs) financial
"These shares are represented by restricted stock units (RSUs) granted under the Second Amended and Restated 2018 Stock Incentive Plan."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with an exercise price of 298.4800 per share on common stock."
Second Amended and Restated 2018 Stock Incentive Plan financial
"RSUs granted under the Second Amended and Restated 2018 Stock Incentive Plan."
vesting financial
"The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ALNY director Amy W. Schulman report on this Form 4 for ALNY?
Amy W. Schulman reported equity compensation grants, not open-market trading. She received 838 restricted stock units and stock options on 1,802 shares, both awarded on May 20, 2026 under a company stock incentive plan.
How many Alnylam (ALNY) RSUs did Amy W. Schulman receive?
She received 838 restricted stock units (RSUs). Each RSU represents a contingent right to one share of Alnylam common stock, subject to vesting conditions tied to time and certain retirement or resignation scenarios described in the filing.
What stock options were granted to Amy W. Schulman by Alnylam (ALNY)?
She was granted stock options on 1,802 shares of Alnylam common stock. These options have a $298.48 exercise price, vest in full after specified conditions, and expire on May 20, 2036 if not exercised earlier.
When do Amy W. Schulman’s new Alnylam (ALNY) RSUs and options vest?
Both the RSUs and the stock options vest in full on the earlier of the first anniversary of the May 20, 2026 grant date, or a qualifying retirement or resignation occurring no more than 90 days before that anniversary.
Are Amy W. Schulman’s Alnylam (ALNY) equity awards open-market purchases?
No. The filing characterizes these as compensation-related awards. The RSUs and stock options were granted at no cash cost per share to her, reflecting a grant or award acquisition rather than an open-market buy transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
